CN1074286C - Exterior-applied medicine for treating rheumatism and rheumatoid disease and its preparing process - Google Patents
Exterior-applied medicine for treating rheumatism and rheumatoid disease and its preparing processInfo
- Publication number
- CN1074286C CN1074286C CN98118755A CN98118755A CN1074286C CN 1074286 C CN1074286 C CN 1074286C CN 98118755 A CN98118755 A CN 98118755A CN 98118755 A CN98118755 A CN 98118755A CN 1074286 C CN1074286 C CN 1074286C
- Authority
- CN
- China
- Prior art keywords
- cortex
- rheumatoid
- exterior
- rheumatism
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses exterior-applied medicine for treating rheumatism and rheumatoid diseases and a preparing method. The exterior-applied medicine is traditional Chinese medicine for treating the arthralgia of rheumatism and rheumatoid diseases. The exterior-applied medicine uses slenderstyle acanthopanax bark, kadsura root-bark, Chinese alangium root and wolfberry bark as major ingredients and selects fresh elm bark or white wine as auxiliary materials. The exterior-applied medicine is prepared by the technologies, such as the cleanness of the major ingredients, drying, respective pulverization, grinding, sieving to 120 to 140 granule meshes, blending, separate loading, etc. The present invention has special therapeutic effects on the arthralgia of rheumatoid diseases. The present invention has the advantages of obvious effects, favorable effects, no poison to the human body, harmlessness, no side effects and no anaphylactic reaction.
Description
The present invention relates to a kind of Chinese medicine for the treatment of rheumatic and rheumatoid numbness disease and preparation method thereof.
Rheumatism, rheumatoid numbness disease are commonly encountered diseases, the frequently-occurring diseases of harm people ' s health.How traditional treatment rheumatoid numbness disease all is that curative effect is undesirable based on oral medicine, also has side effect sometimes.Traditional medicine for external use " cold loosing pulled out in military force " though dispel the wind, just seems powerless to the patient that endogenous dampness or exogenous damp are arranged.Still there are not a kind of application compress can cure the good medicine of rheumatoid numbness disease at present both at home and abroad.
The objective of the invention is to provide a kind of and can effectively treat rheumatism, rheumatoid, particularly have a kind of external application of unique curative effect to loose arthralgia due to stagnation of blood (doctor trained in Western medicine claims phlebitis, varicosis).
Another object of the present invention provides the preparation method that this external application is loose.
Solution of the present invention is based on motherland's medical science to rheumatism, the understanding and the Therapeutic Principle of rheumatoid numbness etiopathogenesis achieve with reference to modern pharmacological research, from motherland's medicine treasure-house, filtering out cold energy stimulates the menstrual flow, the also active wind that pulls out of heat becomes to trembling with fear natural plant by the theory of Chinese medical science prescription, this external application is loose and is added and subtracted medicine Caulis et Folium Sinapis albee seed and Radix Angelicae Dahuricae according to pathology, property of medicine hyperpyrexia, can improve blood circulation, strengthen blood flow, by external application the telangiectasis number is increased, spill absorption, absorption spills, and makes diastole compacting and systolic pressure often change capillary permeability and changes and change along with its inner chamber.The wet external application of going out is loose and can be made the chemical substances such as soda acid in the body have increase and decrease adjustment to change.Along with local lesion changes, along with metabolic condition changes.Stasis of blood hydrops is swollen owing to the change of blood capillary disappears thereupon.Pain person is obstructed, and logical person is not bitterly.
Medicine of the present invention is made (consumption is a weight portion) by following component:
Slender acanthopanax degree 60-75 part Cortex cercis chinensis 20-30 part Radix Alangii 10-20 part
Cortex Lycii 10-20 part
Another weight proportion scope for preparing this medicine is:
Cortex Acanthopancis 55-65 part Cortex cercis chinensis 15-25 part Radix Alangii 8-15 part
Cortex Lycii 8-15 part
Medicine optimum weight proportioning of the present invention is:
10 parts of 10 parts of Cortex Lycii of 20 portions of Radix Alangiis of 60 parts of Cortex cercis chinensiss of Cortex Acanthopancis
During medicine of the present invention preparation, need according to distinguishing that disease executes disease and select for use bright Cortex ulmi pumilae or Chinese liquor to do attached material to calculate with 100 gram pharmaceutical preparatioies, the bright Cortex ulmi pumilae of optional 500 grams is used for leaching mucus and modulates this medicament, or selects for use 50 grams to be used for modulating this medicament from wine.
Above-mentioned each component is made medicine production method of the present invention is:
1, choose major ingredient Cortex Acanthopancis 60 gram, Cortex cercis chinensis 20 grams, Radix Alangii 10 grams, Cortex Lycii 10 grams by cleaning, drying, pulverize separately, facing-up, be screened to technology such as 120-140 grain order mixing packing and finish.
2, choosing bright Cortex ulmi pumilae 500 grams of attached material goes rough bark to use the tender skin warm water soaking of internal layer extraction in 80 minutes mucus to use when the modulation medicine.Or choose Chinese liquor 50 grams and when the modulation medicine, use.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, the present invention select for use pure Chinese herbal medicine for the raw material each component meet the medicine law regulation nontoxic, harmless to human body, have no side effect, do not have irritated reaction.
2, the present invention for Dressed medicine powder need not be fried in shallow oil, boiled tool have save time, laborsaving, the advantage of economizing the energy.
3, rheumatoid numbness is that the medical science difficult and complicated illness does not still have specific aim treatment both at home and abroad, as the saying goes it is dead person's cancer not.The present invention has special efficacy to rheumatoid numbness, can be described as to replenish domestic and international blank.
Advantages such as 4, the present invention has instant effect hour to calculate treatment time in medical circles, and is effective.
For showing the therapeutic effect of this medicine to rheumatism, rheumatoid numbness, respectively through 100 routine system clinical contrast observations, clinical observation is as table (1,2) table 1 rheumatoid disease to rheumatism (arthritis) rheumatoid disease in the present invention
| Case load | 100 | 100 | ||||
| The paralysis electuary | Use medicine of the present invention | |||||
| Treatment time | Cure | Take a turn for the better | No change | Cure | Take a turn for the better | No change |
| 1 hour | 0 | 100 | 50 | 80 | 20 | |
| 2 hours | 0 | 100 | 70 | 85 | 15 | |
| 3 hours | 0 | 100 | 80 | 90 | 10 | |
| 4 hours | 5 | 95 | 85 | 90 | 10 | |
| 5 hours | 10 | 90 | 85 | 90 | 10 | |
| With examining 1 year | Recurrence | 85 | 90 | 5 | ||
| With examining 2 years | Recurrence | 85 | 90 | 5 | ||
The present invention is 85% to the rheumatoid disease cure rate as seen from Table 1, and is invalid 5%, and effective percentage is 90%.This shows the present invention to having significant curative effect in the treatment of each rheumatoid and rheumatoid numbness, meet " this invention has outstanding substantial characteristics and obvious improvement " table 2 arthritis of regulation in 22 of the Patent Laws
| Case load | 100 | 100 | ||||
| Cold loosing pulled out in military force | Use medicine of the present invention | |||||
| Treatment time | Cure | Take a turn for the better | No change | Cure | Take a turn for the better | No change |
| 1 hour | 10 | 20 | 80 | 60 | 70 | 30 |
| 2 hours | 15 | 30 | 70 | 70 | 80 | 20 |
| 3 hours | 15 | 40 | 60 | 80 | 90 | 10 |
| 4 hours | 20 | 50 | 50 | 95 | 98 | 2 |
| With examining 1 year | Recurrence | Recurrence | 95 | 98 | 2 | |
| With examining 2 years | Recurrence | Recurrence | 95 | 98 | 2 | |
The present invention is to arthritis cure rate 95% as seen from Table 2, effective percentage 98%, inefficiency 2%.
Embodiment:
Weigh main material by following proportioning: Cortex Acanthopancis 60 grams, Cortex cercis chinensis 20 grams, Radix Alangii 10 grams, Cortex Lycii 10 grams.Meet the no red and swollen disease in surface, select Chinese liquor 50 grams.
Production method is as follows: earlier Cortex Acanthopancis, Cortex cercis chinensis, Radix Alangii, Cortex Lycii weighed in proportion then by cleaning, drying, pulverize separately, facing-up, be screened to 120-140 grain order mixing, packing.
Again according to the focus needs or choose bright Cortex ulmi pumilae and remove rough bark (crust) and use the tender skin of internal layer, extracted whole mucus modulation in 80 minutes with warm water soaking and pack or choose Chinese liquor and modulate to pack and make.
Claims (4)
1, a kind of rheumatism, rheumatoid external application for the treatment of is loose and be it is characterized in that it is the medicament of being made by the following weight proportion raw material:
Cortex Acanthopancis 60-75 part Cortex cercis chinensis 20-30 part Radix Alangii 10-20 part
Cortex Lycii 10-20 part
2, a kind of rheumatism, rheumatoid external application for the treatment of according to claim 1 looses wherein that the weight proportion of each raw material is:
60 parts of Cortex Acanthopanciss, 20 parts of Cortex cercis chinensiss, 10 parts of Radix Alangiis, 10 parts of Cortex Lycii.
3, a kind of treatment rheumatism, diffusing wherein each the raw material weight proportioning of rheumatoid external application are:
Cortex Acanthopancis 55-65 part Cortex cercis chinensis 15-25 part Radix Alangii 8-15 part
Cortex Lycii 8-15 part
4, a kind of rheumatism, diffusing preparation method of rheumatoid external application for the treatment of is characterized in that:
Choose major ingredient, Cortex Acanthopancis 60 grams, Cortex cercis chinensis 20 grams, Radix Alangii 10 grams, Cortex Lycii 10 grams by clean, drying, pulverize separately, facing-up, be screened to the packing of 120-140 grain order mixing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98118755A CN1074286C (en) | 1998-09-02 | 1998-09-02 | Exterior-applied medicine for treating rheumatism and rheumatoid disease and its preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98118755A CN1074286C (en) | 1998-09-02 | 1998-09-02 | Exterior-applied medicine for treating rheumatism and rheumatoid disease and its preparing process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1246351A CN1246351A (en) | 2000-03-08 |
| CN1074286C true CN1074286C (en) | 2001-11-07 |
Family
ID=5226094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98118755A Expired - Fee Related CN1074286C (en) | 1998-09-02 | 1998-09-02 | Exterior-applied medicine for treating rheumatism and rheumatoid disease and its preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1074286C (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1111152A (en) * | 1995-03-27 | 1995-11-08 | 杨魁杰 | Medicated wine for treatment of arthralgia and its preparation |
| CN1164398A (en) * | 1996-05-03 | 1997-11-12 | 陈列 | Easy-to-use reparcussive pain-stopping plaster |
-
1998
- 1998-09-02 CN CN98118755A patent/CN1074286C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1111152A (en) * | 1995-03-27 | 1995-11-08 | 杨魁杰 | Medicated wine for treatment of arthralgia and its preparation |
| CN1164398A (en) * | 1996-05-03 | 1997-11-12 | 陈列 | Easy-to-use reparcussive pain-stopping plaster |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1246351A (en) | 2000-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1099867C (en) | Face-care prepn. contg. natural ingredients | |
| CN1244373C (en) | Chinese medicinal composition for cholecystitis and preparing method thereof | |
| CN102178903B (en) | Method for preparing traditional Chinese medicine for treating acute pancreatitis caused by overeating greasy food | |
| CN100406050C (en) | A Chinese traditional medicinal preparation for improving sub-health disease | |
| CN102671097A (en) | Oral traditional Chinese medicine composition for treating coronary heart disease | |
| CN1074286C (en) | Exterior-applied medicine for treating rheumatism and rheumatoid disease and its preparing process | |
| CN100534501C (en) | External use medicine liquid for treating alopecia | |
| CN102988747B (en) | Aristida triseta electuary for reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof | |
| CN105998217A (en) | Traditional Chinese medicine composition for treating cervical spondylosis and preparation method | |
| CN112076305A (en) | A Chinese medicinal oral and topical stock solution mixture for treating metabolic syndrome and resisting bacteria and inflammation | |
| CN1275623C (en) | Green peach hull and psoralea fruit containing liquor for treating leucoderma and alphos | |
| CN114767794B (en) | Traditional Chinese medicine for treating arterial plaque | |
| CN1183969A (en) | Chinese medicine for diabetes and its production process | |
| CN1097454C (en) | Weight-lossing essence for human body | |
| CN1686472A (en) | Chinese medicinal product for protecting liver and freezing bowel | |
| CN105288064A (en) | Heart-nourishing and nerve-soothing preparation for patient with anxiety neurosis and preparation method thereof | |
| CN105148182A (en) | Traditional Chinese medicinal pill for treating angina pectoris and preparation method of traditional Chinese medicinal pill | |
| CN1170573C (en) | Trichogen and its prepn | |
| CN104547518A (en) | Traditional Chinese medicine spray for preventing and treating acute heart failure and preparation method thereof | |
| CN1238952A (en) | Chinese-medicinal composition for treating rheumatic and rheumatoid diseases | |
| CN101199342A (en) | Weight reduction health-care food and its preparation method | |
| CN117205250A (en) | Medicine for treating vitiligo | |
| CN108992534A (en) | One kind, which disappears, dislikes peaceful Chinese medicine composition | |
| CN105106853A (en) | Motherwort fruit oral liquid | |
| CN102670933A (en) | Orally-taken traditional Chinese medicine for treating coronary heart diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |